References
- American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders. DSM-5. 5th ed. Washington, DC: American Psychiatric Publishing; 2013.
- Polanczyk GV, Salum GA, Sugaya LS, Caye A, Rohde LA. Annual research review: a meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. J Child Psychol Psychiatry. 2015;56:345–65. doi:https://doi.org/10.1111/jcpp.12381.
- Kaye S, Ramos-Quiroga JA, van de Glind G, Levin FR, Faraone SV, Allsop S, Degenhardt L, Moggi F, Barta C, Konsteninus M, et al. Persistence and subtype stability of ADHD among substance use disorder treatment seekers. J Atten Disord. 2016. doi:https://doi.org/10.1177/1087054716629217.
- Wilens TE, Spencer TJ. Understanding attention-deficit/hyperactivity disorder from childhood to adulthood. Postgrad Med. 2010;122:97–109. doi:https://doi.org/10.3810/pgm.2010.09.2206.
- Lee SS, Humphreys KL, Flory K, Liu R, Glass K. Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review. Clin Psychol Rev. 2011;31:328–41.
- Molina BS, Pelham WE. Attention-deficit/hyperactivity disorder and risk of substance use disorder: developmental considerations, potential pathways, and opportunities for research. Annu Rev Clin Psychol. 2014;10:607–39. doi:https://doi.org/10.1146/annurev-clinpsy-032813-153722.
- Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, Faraone SV, Greenhill LL, Howes MJ, Secnik K, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163:716–23.
- Charach A, Yeung E, Climans T, Lillie E. Childhood attention-deficit/hyperactivity disorder and future substance use disorders: comparative meta-analyses. J Am Acad Child Adolesc Psychiatry. 2011;50:9–21.
- Fatséas M, Hurmic H, Serre F, Debrabant R, Daulouède JP, Denis C, Auriacombe M. Addiction severity pattern associated with adult and childhood attention deficit hyperactivity disorder (ADHD) in patients with addictions. Psychiatry Res. 2016;246:656–62. doi:https://doi.org/10.1016/j.psychres.2016.10.071.
- Olsson MO, Öjehagen A, Bradvic L, Kronstrand R, Håkansson A. High rates of tramadol use among treatment-seeking adolescents in Malmö, Sweden: a study of hair analysis of nonmedical prescription opioid use. J Addict. 2017;2017:1–9. doi:https://doi.org/10.1155/2017/6716929.
- Dart RC, Surratt HL, Cicero TJ, Parrino MW, Severtson SG, Bucher-Bartelson B, Green JL. Trends in opioid analgesic abuse and mortality in the United States. N Engl J Med. 2015;372:241–48. doi:https://doi.org/10.1056/nejmsa1406143.
- Giraudon I, Lowitz K, Dargan PI, Wood DM, Dart RC. Prescription opioid abuse in the UK. Br J Clin Pharmacol. 2013;76:823–24. doi:https://doi.org/10.1111/bcp.12133.
- Novak SP, Håkansson A, Martinez-Raga J, Reimer J, Krotki K, Varughese S. Nonmedical use of prescription drugs in the European Union. BMC Psychiatry. 2016;16. doi:https://doi.org/10.1186/s12888-016-0909-3.
- Zozel A, Buchel-Bartenson B, Bailey E, Lowenstein S, Dart RC. Characterization of adolescent prescription drug abuse and misuse using the researched abuse diversion and addiction-related surveillance (RADARS®) system. J Am Acad Child Adolesc Psychiatry. 2013;52:196–204. doi:https://doi.org/10.1016/j.jaac.2012.11.014.
- Mohamed NR, El Hamrawy LG, Shalaby AS, El Bahy MS, Abd Allah MM. An epidemiological study of tramadol HCl dependence in an outpatient addiction clinic at Heliopolis Psychiatric Hospital. Menoufia Med J. 2015;28:591–96. doi:https://doi.org/10.4103/1110-2098.163924.
- Tjäderborn M, Jönsson AK, Ahlner J, Hägg S. Tramadol dependence: a survey of spontaneously reported cases in Sweden. Pharmacoepidemiol Drug Saf. 2009;18:1192–98. doi:https://doi.org/10.1002/pds.1838.
- Babalonis S, Lofwall MR, Nuzzo PA, Siegel AJ, Walsh SL. Abuse liability and reinforcing efficacy of oral tramadol in humans. Drug Alcohol Depend. 2013;129:116–24. doi:https://doi.org/10.1016/j.drugalcdep.2012.09.018.
- Randall C, Crane J. Tramadol deaths in Northern Ireland: a review of cases from 1996 to 2012. J Forensic Leg Med. 2014;23:32–36. doi:https://doi.org/10.1016/j.jflm.2014.01.006.
- Shadnia S, Soltaninejad K, Heydari K, Sasanian G, Abdollahi M. Tramadol intoxication: a review of 114 cases. Hum Exp Toxicol. 2008;27:201–05. doi:https://doi.org/10.1177/0960327108090270.
- Jovanović-Čupić V, Ž M, Nešić N. Seizures associated with intoxication and abuse of tramadol. Clin Toxicol. 2006;44:143–46. doi:https://doi.org/10.1080/1556365050014418.
- Rahimi HR, Soltaninejad K, Shadnia S. Acute tramadol poisoning and its clinical and laboratory findings. J Res Med Sci. 2014;19:855.
- Häkkinen M, Vuori E, Ojanperä I. Prescription opioid abuse based on representative postmortem toxicology. Forensic Sci Int. 2014;245:121–25. doi:https://doi.org/10.1016/j.forsciint.2014.10.028.
- Bassiony MM, Salah El-Deen GM, Yousef U, Raya Y, Abdel-Ghani MM, ElGohari H, Atwa SA. Adolescent tramadol use and abuse in Egypt. Am J Drug Alcohol Abuse. 2015;41:206–11. doi:https://doi.org/10.3109/00952990.2015.1014959.
- Nazarzadeh M, Bidel Z, Carson KV. The association between tramadol hydrochloride misuse and other substances use in an adolescent population: phase I of a prospective survey. Addict Behav. 2014;39:333–37. doi:https://doi.org/10.1016/j.addbeh.2013.09.013.
- Maiga DD, Seyni H, Moussa AO, Sidikou A. Tramadol misuse by adolescents and young adults living on the streets. Pan Afr Med J. 2012;13:55.
- Alblooshi H, Hulse GK, El Kashef A, Al Hashmi H, Shawky M, Al Ghaferi H, Al Safar H, Tay GK. The pattern of substance use disorder in the United Arab Emirates in 2015: results of a National Rehabilitation Centre cohort study. Subst Abuse Treat Prev Policy. 2016;11. doi:https://doi.org/10.1186/s13011-016-0062-5.
- Hodgins S, Larm P, Molero-Samuleson Y, Tengström A, Larsson A. Multiple adverse outcomes over 30 years following adolescent substance misuse treatment. Acta Psychiatr Scand. 2009;119:484–93. doi:https://doi.org/10.1111/j.1600-0447.2008.01327.x.
- Dean AG, Arner TG, Sunki GG, Friedman R, Lantinga M, Sangam S, Zubieta JC, Sullivan KM, Brendel KA, Gao Z, et al. Epi Info™, a database and statistics program for public health professionals. Atlanta: CDC; 2011.
- First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV axis I disorders, clinician version (SCIDCV). Washington, DC: American Psychiatric Press; 1996.
- Berman AH, Bergman H, Palmstierna T, Schlyter F. Evaluation of the drug use disorders identification test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. Eur Addict Res. 2005;11:22–31. doi:https://doi.org/10.1159/000081413.
- IBM Corp. IBM SPSS statistics for windows, Version 27.0. Armonk, NY: IBM Corp; Released 2020.
- Bassiony MM, Salah El-Deen G, Abdelghani M, Youssef UM, Hassan MS, El-Gohari H. Addressing prevalence and correlates among a sample of Egyptian University students who suffer from substance use disorders. Addict Disord Their Treat. 2018;17:114–23. doi:https://doi.org/10.1097/ADT.0000000000000131.
- Bassiony MM, Abdelghani M, Salah El-Deen GM, Hassan MS, El-Gohari H, Youssef UM. Opioid use disorders attributed to tramadol among Egyptian university students. J Addict Med. 2018;12:150–55. doi:https://doi.org/10.1097/ADM.0000000000000380.
- Boyd CJ, McCabe SE. Coming to terms with the nonmedical use of prescription medications. Subst Abuse Treat Prev Policy. 2008;3:22. doi:https://doi.org/10.1186/1747-597X-3-22.
- John A, Bumpus JA. Low-dose tramadol as an off-label antidepressant: a data mining analysis from the patients’ perspective. ACS Pharmacol Transl Sci. 2020;3:1293–303. doi:https://doi.org/10.1021/acsptsci.0c00132.
- Findling R, Greenhill L, Reed M. Venlafaxine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2007;17:433–45. doi:https://doi.org/10.1089/cap.2007.0119.
- Zarinara A, Mohammadi M, Akhondzadeh S. Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial. Hum Psychopharmacol. 2010;25:530–35. doi:https://doi.org/10.1002/hup.1148.
- Firoozkoohi M, Arabgol F, Rajezi S. Efficacy of venlafaxine and methylphenidate in the treatment of children with attention deficit hyperactivity disorder. Zahedan J Res Med Sci. 2008;10:69–77.
- Mukades NM, Abali O. Venlafaxine in children and adolescents with attention deficit hyperactivity disorder. Psychiatry Clin Neurosc. 2004;58:92–95. doi:https://doi.org/10.1111/j.1440-1819.2004.01199.x.
- Upadhyaya HP, Brady KT, Sethurraman G, Sonne SC, Malcolm R. Venlafaxine treatment of patients with comorbid alcohol/21ocaine abuse and attention‐deficit/hyperactivity disorder: a pilot study. J Clin Psychopharmacol. 2001;21:116–18. doi:https://doi.org/10.1097/00004714-200102000-00025.
- Park P, Caballero J, Omidian H. Use of serotonin norepinephrine reuptake inhibitors in the treatment of attention-deficit hyperactivity disorder in pediatrics. Ann Pharmacother. 2013. doi:https://doi.org/10.1177/1060028013506561.
- Mahmoudi-Gharaei J, Dodangi N, Tehrani-Doost M. Duloxetine in the treatment of adolescents with attention deficit/hyperactivity disorder: an open-label study. Hum Psychopharmacol. 2011;26:155–60. doi:https://doi.org/10.1002/hup.1188.
- Herman-Stahl MA, Krebs CP, Kroutil LA, Heller DC. Risk and protective factors for methamphetamine use and nonmedical use of prescription stimulants among young adults aged 18 to 25. Addict Behav. 2007;32:1003–15. doi:https://doi.org/10.1016/j.addbeh.2006.07.010.
- Reyna VF, Farley F. Risk and rationality in adolescent decision making: implications for theory, practice, and public policy. Psychol Sci Public Interest. 2006;7:1–44. doi:https://doi.org/10.1111/j.1529-1006.2006.00026.x.
- Zuckerman M, Kuhlman DM. Personality and risk taking: common biosocial factors. J Pers. 2000;68:999–1029. doi:https://doi.org/10.1111/1467-6494.00124.
- Low KG, Gendaszek AE. Illicit use of psychostimulants among college students: a preliminary study. Psychol Health Med. 2002;7:283–87. doi:https://doi.org/10.1080/13548500220139386.
- Van Eck K, Markle RS, Flory K. Do conduct problems and sensation seeking moderate the association between ADHD and three types of stimulant use in a college population? Psychol Addict Behav. 2012;26:939–47. doi:https://doi.org/10.1037/a0027431.
- Bassiony MM, Fawzy M, Negm M, Ibrahim EF, Ibrahim D, Mokhtar D, Abdallah A, Saad A. Substance use disorders among industry workers in Egypt. Addict Disord Their Treat. 2019;18:185–93. doi:https://doi.org/10.1097/ADT.0000000000000162.